Waddell & Associates’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$552K Buy
10,149
+361
+4% +$17.6K 0.03% 254
2026
Q1
$420K Sell
9,788
-1,704
-15% -$73.3K 0.02% 269
2025
Q4
$504K Buy
+11,492
New +$475K 0.03% 171

Other funds holding EXEL

Waddell & Associates's EXEL Position: Q2 2026 in Review

Waddell & Associates increased its Exelixis (EXEL) stake by 3.7% in Q2 2026, buying an estimated $17.6K and bringing the position to 10,149 shares worth $552K. The position accounts for 0.03% of the portfolio, ranked #254.

Waddell & Associates first reported a position in EXEL in Q4 2025 and has held it in 3 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Waddell & Associates held 10,149 shares of Exelixis worth $552K as of Q2 2026.
  • Waddell & Associates bought 361 Exelixis shares in Q2 2026, an estimated $17.6K.
  • Exelixis made up 0.03% of Waddell & Associates's portfolio in Q2 2026, its #254 holding.
  • Waddell & Associates first reported a position in Exelixis in Q4 2025 and has held it in 3 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.